Left Atrial Apendix Closure

AHA 2025 | CLOSURE-AF: Left Atrial Appendage Occlusion (LAAO) vs. Medical Therapy in Atrial Fibrillation with High Stroke and Bleeding Risk

Atrial fibrillation (AF) is a complex condition in which patients often present with multiple comorbidities, including high...

Dr. Omar Tupayachi - 13 November, 2025

Learn More

Left Atrial Apendix Closure

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population...

Dr. Andrés Rodríguez - 5 November, 2025

Learn More

Antiplatelet

TCT 2025 | ANDES Trial: Short-Term DOAC vs. DAPT After Percutaneous Left Atrial Appendage Occlusion

Percutaneous left atrial appendage occlusion (LAAO) is an established alternative to chronic anticoagulation in patients with non-valvular...

Dr. Omar Tupayachi - 30 October, 2025

Learn More

Antithrombotic Anticoagulants

8 Questions About Left Atrial Appendage Closure: Contributions from the 2025 SCAI/HRS Review

Courtesy of Dr. Juan Manuel Pérez. Percutaneous left atrial appendage occlusion (LAAO) is an alternative to oral anticoagulation...

Dr. Juan Manuel Pérez - 28 August, 2025

Learn More

Left Atrial Apendix Closure

Clinical Impact of Peridevice Leak Following Left Atrial Appendage Closure

Left atrial appendage closure (LAAO) has consolidated as a valid strategy for thromboembolic event prevention in patients...

Dr. Omar Tupayachi - 26 August, 2025

Learn More

Left Atrial Apendix Closure

Early and Late Readmission after Left Atrial Appendage Closure

Percutaneous left atrial appendage closure (LAAC) represents an effective alternative for patients with atrial fibrillation and anticoagulation...

Dr. Juan Manuel Pérez - 7 July, 2025

Learn More

Left Atrial Apendix Closure

Watchman FLX and Improvement Impact vs. 2.5

Left atrial appendage occlusion (LAAO) represents an effective alternative to oral anticoagulation (OAC) in patients with non-valvular...

Dr. Omar Tupayachi - 17 June, 2025

Learn More

Left Atrial Apendix Closure

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access...

Dr. Omar Tupayachi - 1 November, 2024

Learn More

Left Atrial Apendix Closure

AHA 2025 | CLOSURE-AF: Left Atrial Appendage Occlusion (LAAO) vs. Medical Therapy in Atrial Fibrillation with High Stroke and Bleeding Risk

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

TCT 2025 | ANDES Trial: Short-Term DOAC vs. DAPT After Percutaneous Left Atrial Appendage Occlusion

8 Questions About Left Atrial Appendage Closure: Contributions from the 2025 SCAI/HRS Review

Clinical Impact of Peridevice Leak Following Left Atrial Appendage Closure

Early and Late Readmission after Left Atrial Appendage Closure

Watchman FLX and Improvement Impact vs. 2.5

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Access